PreprintCited by 1,245Cancer-related Molecular PathwaysTelomeres, Telomerase, and SenescenceCell death mechanisms and regulation

The DOI matches its Crossref record; 55 of the 60 references it cites were found in a registry or an index.

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

Open access

Zindy, Frederique, Eischen, Christine M., Randle, David H., Kamijo, Takehiko, Cleveland, John L., Sherr, Charles J., Roussel, Martine F.·1998·Genes & Development

DOI 10.1101/gad.12.15.2424PMC PMC317045

Open this paper in CoChat — free account Open PDF

Abstract

Establishment of primary mouse embryo fibroblasts (MEFs) as continuously growing cell lines is normally accompanied by loss of the p53 or p19(ARF) tumor suppressors, which act in a common biochemical pathway. myc rapidly activates ARF and p53 gene expression in primary MEFs and triggers replicative crisis by inducing apoptosis. MEFs that survive myc overexpression sustain p53 mutation or ARF loss during the process of establishment and become immortal. MEFs lacking ARF or p53 exhibit an attenuated apoptotic response to myc ab initio and rapidly give rise to cell lines that proliferate in chemically defined medium lacking serum. Therefore, ARF regulates a p53-dependent checkpoint that safeguards cells against hyperproliferative, oncogenic signals.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1101/gad.12.15.2424

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
Cancer Cell Cycles
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Self-citation
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 2×
“Expression of activated ras in primary MEFs inhibits cell growth (Serrano et al. 1997), whereas overexpression of myc in these same cells triggers apoptosis, a process further aggravated by withdrawal of serum survival factors (Evan et al. 1992).”
Background
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,691
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 2×
“In turn, Mdm2 acts in a feedback loop to catalyze p53 ubiquitination and degrada- tion, limiting the p53 response (Haupt et al. 1997; Honda et al. 1997; Kubbutat et al. 1997).”
Background
Induction of apoptosis in fibroblasts by c-myc protein
Evan, G. I., Wyllie, A. H., Gilbert, C. S., Littlewood, T. D., Land, H., Brooks, M. W., Waters, C. M., Penn, L. Z., & Hancock, D. C. (1992) · Cell · doi:10.1016/0092-8674(92)90123-t · Cited by 2,941
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804

Flagged first, then by citations

Show all 60 references

5 of the 60 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

10.1126/science.256.5058.827 · DOI

Sorted by citations

Items 301–400 of 1,001

FoxO transcription factors suppress Myc-driven lymphomagenesis via direct activation of ArfPreprint
Bouchard, C., Lee, S., Paulus-Hock, V., Loddenkemper, C., Eilers, M., & Schmitt, C. A. (2007) · Genes & Development · doi:10.1101/gad.453107 · Cited by 135
The DNA Damage Signaling Pathway Connects Oncogenic Stress to Cellular Senescence
Mallette, F. A., & Ferbeyre, G. (2007) · Cell Cycle · doi:10.4161/cc.6.15.4516 · Cited by 125
MDM2 and MDMX: Alone and together in regulation of p53.
Shadfan, M., Lopez-Pajares, V., & Yuan, Z.-M. (2012) · PubMed · Cited by 125
Receptor- and mitochondrial-mediated apoptosis in acute leukemia: a translational view
Schimmer, A. D., Hedley, D. W., Penn, L. Z., & Minden, M. D. (2001) · Blood · doi:10.1182/blood.v98.13.3541 · Cited by 125
Modulatory calcineurin-interacting proteins 1 and 2 function as calcineurin facilitators in vivo
Sanna, B., Brandt, E. B., Kaiser, R. A., Pfluger, P. T., Witt, S. A., Kimball, T. R., van Rooij, E., Windt, L. J. D., Rothenberg, M. E., Tschöp, M. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509340103 · Cited by 127
Sumoylation induced by the Arf tumor suppressor: A p53-independent function
Tago, K., Chiocca, S., & Sherr, C. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502978102 · Cited by 124
Self-citation
Induction of p21 WAF1/CIP1 and Inhibition of Cdk2 Mediated by the Tumor Suppressor p16 INK4a
Mitra, J., Dai, C. Y., Somasundaram, K., El‐Deiry, W. S., Satyamoorthy, K., Herlyn, M., & Enders, G. H. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3916 · Cited by 125
Modeling mutations in the G1 arrest pathway in human gliomas: overexpression of CDK4 but not loss of INK4a–ARF induces hyperploidy in cultured mouse astrocytesPreprint
Holland, E. C., Hively, W. P., Gallo, V., & VARMUS, H. E. (1998) · Genes & Development · doi:10.1101/gad.12.23.3644 · Cited by 124
Egr1 mediates p53-independent c-Myc–induced apoptosis via a noncanonical ARF-dependent transcriptional mechanism
Boone, D. N., Qi, Y., Li, Z., & Hann, S. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008848108 · Cited by 122
Regulation of the MDM2-p53 Pathway by Ribosomal Protein L11 Involves a Post-ubiquitination Mechanism
Dai, M., Shi, D., Jin, Y., Sun, X., Zhang, Y., Grossman, S. R., & Lu, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602596200 · Cited by 124
GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors
Kazi, A., Xiang, S., Yang, H., Delitto, D., Trevino, J. G., Jiang, R. H. Y., Ayaz, M., Lawrence, H. R., Kennedy, P., & Sebti, S. M. (2018) · Nature Communications · doi:10.1038/s41467-018-07644-6 · Cited by 122
Defining the molecular basis of Arf and Hdm2 interactions
Bothner, B. B., Lewis, W. S., DiGiammarino, E. L., Weber, J. D., Bothner, S. J., & Kriwacki, R. W. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5110 · Cited by 122
“Myc’ed Messages”: Myc Induces Transcription of E2F1 while Inhibiting Its Translation via a microRNA Polycistron
Coller, H. A., Forman, J. J., & Legesse-Miller, A. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030146 · Cited by 122
Increased apoptosis induction by 121F mutant p53
Saller, E., Tom, E., Brunori, M., Otter, M., Estreicher, A., Mack, D. H., & Iggo, R. D. (1999) · The EMBO Journal · doi:10.1093/emboj/18.16.4424 · Cited by 124
Ras-Raf-Arf Signaling Critically Depends on the Dmp1 Transcription Factor
Sreeramaneni, R., Chaudhry, A., McMahon, M., Sherr, C. J., & Inoue, K. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.220-232.2005 · Cited by 123
Self-citation
Making decisions through Myc
Nasi, S., Ciarapica, R., Jucker, R., Rosati, J. D., & Soucek, L. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02118-4 · Cited by 121
Multiple Stress Signals Activate Mutant p53 In Vivo
Suh, Y., Post, S. M., Elizondo-Fraire, A. C., Macció, D. R., Jackson, J. G., El‐Naggar, A. K., Pelt, C. V., Terzian, T., & Lozano, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0459 · Cited by 119
dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53
Martoriati, A., Doumont, G., Alcalay, M., Bellefroid, E., Pelicci, P. G., & Marine, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208256 · Cited by 119
AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1
Nishida, S., Hosen, N., Shirakata, T., Kanato, K., Yanagihara, M., Nakatsuka, S., Hoshida, Y., Nakazawa, T., Harada, Y., Tatsumi, N., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1656 · Cited by 118
Induction of Cell Cycle Progression and Acceleration of Apoptosis Are Two Separable Functions of c-Myc: Transrepression Correlates with Acceleration of Apoptosis
Conzen, S. D., Gottlob, K., Kandel, E., Khanduri, P., Wagner, A. J., O'Leary, M., & Hay, N. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.16.6008-6018.2000 · Cited by 118
c-Myc inactivation of p53 through the pan-cancer lncRNA MILIP drives cancer pathogenesis
Feng, Y., Liu, X., Liu, T., Ji, Q., Wu, Y., Li, J., Gao, W., Zhang, Y. Y., La, T., Tabatabaee, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18735-8 · Cited by 119
Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
Kamijo, T., van de Kamp, E. H., Chong, M. J., Zindy, F., Diehl, J. A., Sherr, C. J., & McKinnon, P. J. (1999) · PubMed · Cited by 117
Self-citation
p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice
Eymin, B., Leduc, C., Coll, J., Brambilla, E. M., & Gazzéri, S. (2003) · Oncogene · doi:10.1038/sj.onc.1206303 · Cited by 117
ATM is a target for positive regulation by E2F-1
Berkovich, E., & Ginsberg, D. (2003) · Oncogene · doi:10.1038/sj.onc.1206144 · Cited by 117
Perspectives on c-Myc, Cyclin D1, and Their Interaction in Cancer Formation, Progression, and Response to Chemotherapy
Liao, D. J., Thakur, A. B., Wu, J., Biliran, H., & Sarkar, F. H. (2007) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.v13.i2.10 · Cited by 116
The cytoplasmic Purkinje onconeural antigen cdr2 down-regulates c-Myc function: implications for neuronal and tumor cell survivalPreprint
Okano, H. J., Park, W.-Y., Corradi, J., & Darnell, R. B. (1999) · Genes & Development · doi:10.1101/gad.13.16.2087 · Cited by 117
Characterization of a Novel Cytotoxic Cell‐penetrating Peptide Derived From p14ARF Protein
Johansson, H. J., Andaloussi, S. E., Holm, T., Mäe, M. A., Jänes, J., Maimets, T., & Langel, Ü. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300346 · Cited by 119
BACH2 mediates negative selection and p53-dependent tumor suppression at the pre-B cell receptor checkpoint
Swaminathan, S., Huang, C., Geng, H., Chen, Z., Harvey, R. C., Kang, H., Ng, C., Titz, B., Hurtz, C., Sadiyah, F., et al. (2013) · Nature Medicine · doi:10.1038/nm.3247 · Cited by 114
Pituitary Tumor Transforming Gene Causes Aneuploidy and p53-dependent and p53-independent Apoptosis
Yu, R., Heaney, A. P., Lu, W., Chen, J., & Melmed, S. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000546200 · Cited by 114
Policing of oncogene activity by p53
Efeyan, A., García-Cao, I., Herranz, D., Velasco-Miguel, S., & Serrano, M. (2006) · Nature · doi:10.1038/443159a · Cited by 116
MicroRNAs as regulators and mediators of c-MYC function
Jackstadt, R., & Hermeking, H. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.04.003 · Cited by 117
Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis
Diolaiti, D., McFerrin, L. G., Carroll, P. A., & Eisenman, R. N. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.05.016 · Cited by 115
Involvement of the INK4a/Arf gene locus in senescence
Collins, C. J., & Sedivy, J. M. (2003) · Aging Cell · doi:10.1046/j.1474-9728.2003.00048.x · Cited by 113
Mutations in the INK4a/ARF Melanoma Susceptibility Locus Functionally Impair p14ARF
Rizos, H., Darmanian, A., Holland, E. A., Mann, G. J., & Kefford, R. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105299200 · Cited by 113
Activation of p53 by oncogenes.
Lowe, S. W. (1999) · Endocrine Related Cancer · doi:10.1677/erc.0.0060045 · Cited by 117
Trib1 links the MEK1/ERK pathway in myeloid leukemogenesis
Yokoyama, T., Kanno, Y., Yamazaki, Y., Takahara, T., Miyata, S., & Nakamura, T. (2010) · Blood · doi:10.1182/blood-2009-10-246264 · Cited by 119
p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53
Wasylyk, C., Salvi, R., Argentini, M., Dureuil, C., Delumeau, I., Abecassis, J., Debüssche, L., & Wasylyk, B. (1999) · Oncogene · doi:10.1038/sj.onc.1202528 · Cited by 112
Myc-ARF (Alternate Reading Frame) Interaction Inhibits the Functions of Myc
Datta, A., Nag, A., Pan, W., Hay, N., Gartel, A. L., Colamonici, O. R., Mori, Y., & Raychaudhuri, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312305200 · Cited by 113
Malignant Transformation but not Normal Cell Growth Depends on Signal Transducer and Activator of Transcription 3
Schlessinger, K., & Levy, D. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0317 · Cited by 112
p53 pathway dysfunction is highly prevalent in acute myeloid leukemia independent of TP53 mutational status
Quintás‐Cardama, A., Hu, C., Qutub, A. A., Qiu, Y. H., Zhang, X., Post, S. M., Zhang, N., Coombes, K. R., & Kornblau, S. M. (2016) · Leukemia · doi:10.1038/leu.2016.350 · Cited by 116
E2F1 Induces Phosphorylation of p53 That Is Coincident with p53 Accumulation and Apoptosis
Rogoff, H. A., Pickering, M., Debatis, M. E., Jones, S. N., & Kowalik, T. F. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5308-5318.2002 · Cited by 111
The Role of MIZ-1 in MYC-Dependent TumorigenesisPreprint
Wiese, K. E., Walz, S., von Eyß, B., Wolf, E., Athineos, D., Sansom, O. J., & Eilers, M. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014290 · Cited by 114
A functional screen identifies hDRIL1 as an oncogene that rescues RAS-induced senescence
Peeper, D. S., Shvarts, A., Brummelkamp, T. R., Douma, S., Koh, E. Y., Daley, G. Q., & Bernards, R. (2002) · Nature Cell Biology · doi:10.1038/ncb742 · Cited by 111
The Absence of p53 Promotes Metastasis in a Novel Somatic Mouse Model for Hepatocellular Carcinoma
Lewis, B. C., Klimstra, D. S., Socci, N. D., Xu, S., Koutcher, J. A., & VARMUS, H. E. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.4.1228-1237.2005 · Cited by 112
Recent advances in research on multistage tumorigenesis
Compagni, A., & Christofori, G. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1309 · Cited by 111
Lens Fibre Cell Differentiation – A Link with Apoptosis?
Dahm, R. (1999) · Ophthalmic Research · doi:10.1159/000055530 · Cited by 110
ARF Function Does Not Require p53 Stabilization or Mdm2 Relocalization
Korgaonkar, C. K., Zhao, L., Modestou, M., & Quelle, D. E. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.1.196-206.2002 · Cited by 111
Telomere dysfunction alters the chemotherapeutic profile of transformed cells
Lee, K.-H., Rudolph, K. L., Ju, Y.-J., Greenberg, R. A., Cannizzaro, L. A., Chin, L., Weiler, S. R., & DePinho, R. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051629198 · Cited by 111
Nucleolar stress: From development to cancer
Lafita‐Navarro, M. C., & Conacci‐Sorrell, M. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.04.001 · Cited by 109
Myeloid Leukemia-Associated Nucleophosmin Mutants Perturb p53-Dependent and Independent Activities of the Arf Tumor Suppressor Protein
den Besten, W., Kuo, M.-L., Williams, R. T., & Sherr, C. J. (2005) · Cell Cycle · doi:10.4161/cc.4.11.2174 · Cited by 109
Self-citation
How does Epstein–Barr virus (EBV) complement the activation of Myc in the pathogenesis of Burkitt's lymphoma?
Allday, M. J. (2009) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2009.07.007 · Cited by 109
p53-Dependent and p53-Independent Activation of Autophagy by ARF
Abida, W. M., & Gu, W. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2069 · Cited by 109
Adenovirus-mediated overexpression of p14ARF induces p53 and Bax-independent apoptosis
Hemmati, P., Gillissen, B. F., von Haefen, C., Wendt, J., Stärck, L., Güner, D., Dörken, B., & Daniel, P. T. (2002) · Oncogene · doi:10.1038/sj.onc.1205458 · Cited by 109
Haplo-insufficiency? Let me count the ways: Figure 1.Preprint
Quon, K. C., & Berns, A. J. M. (2001) · Genes & Development · doi:10.1101/gad.949001 · Cited by 109
The INK4a/ARF locus in murine tumorigenesis
Serrano, M. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.865 · Cited by 109
Differential effects of p19 Arf and p16 Ink4a loss on senescence of murine bone marrow-derived preB cells and macrophages
Randle, D. H., Zindy, F., Sherr, C. J., & Roussel, M. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171217498 · Cited by 108
Self-citation
An overview of apoptosis and the prevention of colorectal cancer
Watson, A. J. M. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.06.005 · Cited by 108
Concomitant expression of p16INK4a and p14ARF in primary breast cancer and analysis of inactivation mechanisms
Silva, J., Silva, J. M., Domínguez, G., García, J. M., Cantos, B., Rodríguez, R., Larrondo, F. J., Provencio, M., España, P., & Bonilla, F. (2003) · The Journal of Pathology · doi:10.1002/path.1297 · Cited by 107
Unique risk factors for insertional mutagenesis in a mouse model of XSCID gene therapy.
Shou, Y., Ma, Z.-J., Lu, T., & Sorrentino, B. (2006) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.0603635103 · Cited by 116
Disruption of the ARF transcriptional activator DMP1 facilitates cell immortalization, Ras transformation, and tumorigenesisPreprint
Inoue, K., Wen, R., Rehg, J. E., Adachi, M., Cleveland, J. L., Roussel, M. F., & Sherr, C. J. (2000) · Genes & Development · doi:10.1101/gad.14.14.1797 · Cited by 107
Self-citation
Role of Ras/Raf/MEK/ERK signaling in physiological hematopoiesis and leukemia development
Chung, E., & Kondo, M. (2010) · Immunologic Research · doi:10.1007/s12026-010-8187-5 · Cited by 107
DNA Damage Disrupts the p14ARF-B23(Nucleophosmin) Interaction and Triggers a Transient Subnuclear Redistribution of p14ARF
Lee, C., Smith, B. A., Bandyopadhyay, K., & Gjerset, R. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1759 · Cited by 106
Mdm2 Promotes Genetic Instability and Transformation Independent of p53
Bouska, A., Lushnikova, T., Plaza, S., & Eischen, C. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01584-07 · Cited by 105
Self-citation
New roles for the RB tumor suppressor protein
Liu, H., Dibling, B. C., Spike, B. T., Dirlam, A., & Macleod, K. F. (2003) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2003.11.005 · Cited by 107
p14 ARF Activates a Tip60-Dependent and p53-Independent ATM/ATR/CHK Pathway in Response to Genotoxic Stress
Eymin, B., Claverie, P., Salon, C., Leduc, C., Col, E., Brambilla, E. M., Khochbin, S., & Gazzéri, S. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02240-05 · Cited by 111
Dmp1 is haplo-insufficient for tumor suppression and modifies the frequencies of Arf and p53 mutations in Myc-induced lymphomasPreprint
Inoue, K., Zindy, F., Randle, D. H., Rehg, J. E., & Sherr, C. J. (2001) · Genes & Development · doi:10.1101/gad.929901 · Cited by 106
Self-citation
Comparative clinicopathologic and immunohistochemical analysis of uterine sarcomas diagnosed using the World Health Organization classification system
D′Angelo, E., Spagnoli, L. G., & Prat, J. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.03.018 · Cited by 104
Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors
Eymin, B., Gazzéri, S., Brambilla, C., & Brambilla, E. M. (2002) · Oncogene · doi:10.1038/sj.onc.1205359 · Cited by 104
MYCN oncoprotein targets and their therapeutic potential
Bell, E., Chen, L., Liu, T., Marshall, G. M., Lunec, J., & Tweddle, D. A. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.01.015 · Cited by 104
Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer.
Michalides, R. J. A. M. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.8.555 · Cited by 104
Signaling Pathways Activated by Oncogenic Forms of Abl Tyrosine Kinase
Zou, X., & Calame, K. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18141 · Cited by 104
Differential requirement for p19ARF in the p53-dependent arrest induced by DNA damage, microtubule disruption, and ribonucleotide depletion
Khan, S. H., Moritsugu, J., & Wahl, G. M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.7.3266 · Cited by 103
ZBP-89 Promotes Growth Arrest through Stabilization of p53
Bai, L., & Merchant, J. L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.14.4670-4683.2001 · Cited by 103
ΔNp73 Facilitates Cell Immortalization and Cooperates with Oncogenic Ras in Cellular Transformation In Vivo
Petrenko, O., Zaika, A. I., & Moll, U. M. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.16.5540-5555.2003 · Cited by 105
p53-Dependent and -Independent Functions of the Arf Tumor SuppressorPreprint
Sherr, C. J., Bertwistle, D., den Besten, W., KUO, M.-L., SUGIMOTO, M., Tago, K., Williams, R. T., Zindy, F., & Roussel, M. F. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.004 · Cited by 106
Self-citation
Tbx3 impinges on the p53 pathway to suppress apoptosis, facilitate cell transformation and block myogenic differentiation
Carlson, H., Ota, S., Song, Y., Chen, Y., & Hurlin, P. J. (2002) · Oncogene · doi:10.1038/sj.onc.1205476 · Cited by 102
Sumoylation of Mdm2 by Protein Inhibitor of Activated STAT (PIAS) and RanBP2 Enzymes
Miyauchi, Y., Yogosawa, S., Honda, R., Nishida, T., & Yasuda, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208319200 · Cited by 102
The EGF/ErbB Receptor Family and Apoptosis
Danielsen, A. J., & Maihle, N. J. (2002) · Growth Factors · doi:10.1080/08977190290022185 · Cited by 101
Increased DNA Damage Sensitivity and Apoptosis in Cells Lacking the Snf5/Ini1 Subunit of the SWI/SNF Chromatin Remodeling Complex
Klochendler‐Yeivin, A., Pikarsky, E., & Yaniv, M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2661-2674.2006 · Cited by 104
Runx2 and MYC Collaborate in Lymphoma Development by Suppressing Apoptotic and Growth Arrest Pathways In vivo
Blyth, K., Vaillant, F., Hanlon, L., Mackay, N. A., Bell, M., Jenkins, A., Neil, J. C., & Cameron, E. R. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3558 · Cited by 101
p53 regulates Stat3 phosphorylation and DNA binding activity in human prostate cancer cells expressing constitutively active Stat3
Lin, J., Tang, H., Jin, X., Jia, G., & Hsieh, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205426 · Cited by 101
Regulated β-Cell Regeneration in the Adult Mouse Pancreas
Cano, D. A., Rulifson, I. C., Heiser, P. W., Swigart, L. B., Pelengaris, S., German, M. S., Evan, G. I., Bluestone, J. A., & Hebrok, M. (2007) · Diabetes · doi:10.2337/db07-0913 · Cited by 105
Myc-Mediated Proliferation and Lymphomagenesis, but Not Apoptosis, Are Compromised by E2f1 Loss
Baudino, T. A., Maclean, K. H., Brennan, J. A., Parganas, E., Yang, C., Aslanian, A., Lees, J. A., Sherr, C. J., Roussel, M. F., & Cleveland, J. L. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00102-3 · Cited by 101
Self-citation
Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions
Smith, P. D., Crossland, S., Parker, G. A., Osin, P., Brooks, L. A., Waller, J., Philp, E., Crompton, M. R., Gusterson, B. A., Allday, M. J., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202565 · Cited by 101
Targeting of C-Terminal Binding Protein (CtBP) by ARF Results in p53-Independent Apoptosis
Paliwal, S., Pande, S., Kovi, R. C., Sharpless, N. E., Bardeesy, N. M., & Grossman, S. R. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.6.2360-2372.2006 · Cited by 104
Two Phases of Mitogenic Signaling Unveil Roles for p53 and EGR1 in Elimination of Inconsistent Growth Signals
Zwang, Y., Sas‐Chen, A., Drier, Y., Shay, T., Avraham, R., Lauriola, M., Shema, E., Nili, E. L., Jacob‐Hirsch, J., Amariglio, N., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.04.017 · Cited by 100
DAP Kinase—A Proapoptotic Gene That Functions as a Tumor Suppressor
Raveh, T. B., & Kimchi, A. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5134 · Cited by 100
Stress-induced cleavage of Myc promotes cancer cell survivalPreprint
Conacci‐Sorrell, M., Ngouenet, C., Anderson, S., Brabletz, T., & Eisenman, R. N. (2014) · Genes & Development · doi:10.1101/gad.231894.113 · Cited by 107
Arf induces p53-dependent and -independent antiproliferative genes.
Kuo, M.-L., Duncavage, E. J., Mathew, R., den Besten, W., Pei, D., Naeve, D., Yamamoto, T. S., Cheng, C., Sherr, C. J., & Roussel, M. F. (2003) · PubMed · Cited by 99
Self-citation
SMARCAL1 maintains telomere integrity during DNA replication
Poole, L. A., Zhao, R., Glick, G. G., Lovejoy, C. A., Eischen, C. M., & Cortez, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510750112 · Cited by 98
Self-citation
First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus
Pich, D., Mrozek-Górska, P., Bouvet, M., Sugimoto, A., Akidil, E., Grundhoff, A. T., Hamperl, S., Ling, P. D., & Hammerschmidt, W. (2019) · mBio · doi:10.1128/mbio.01723-19 · Cited by 99
The paradox ofE2F1: Oncogene and tumor suppressor gene
Johnson, D. G. (2000) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(200003)27:3 · Cited by 98
Onzin, a c-Myc-repressed target, promotes survival and transformation by modulating the Akt–Mdm2–p53 pathway
Rogulski, K. R., Li, Y., Rothermund, K. D., Pu, L., Watkins, S. C., Yi, F., & Prochownik, E. V. (2005) · Oncogene · doi:10.1038/sj.onc.1208897 · Cited by 96
Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene
Liu, Z., Hergenhahn, M., Schmeiser, H. H., Wogan, G. N., Hong, A., & Hollstein, M. C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308607101 · Cited by 95
TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosis
Dugan, K. A., Wood, M. A., & Cole, M. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205763 · Cited by 100
Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization
Rizos, H., Darmanian, A., Mann, G. J., & Kefford, R. F. (2000) · Oncogene · doi:10.1038/sj.onc.1203629 · Cited by 95
The Oncoprotein Kinase Chaperone CDC37 Functions as an Oncogene in Mice and Collaborates with Both c- myc and Cyclin D1 in Transformation of Multiple Tissues
Stepanova, L., Finegold, M. J., DeMayo, F. J., Schmidt, E. V., & Harper, J. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.12.4462-4473.2000 · Cited by 94
Tumor suppressor p16INK4a determines sensitivity of human cells to transformation by cooperating cellular oncogenes
Drayton, S., Rowe, J., Jones, R., Vatcheva, R., Heavens, D., Marshall, J. F., Fried, M., & Peters, G. G. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00242-3 · Cited by 98
Role of the alternative INK4A proteins in human keratinocyte senescence: evidence for the specific inactivation of p16INK4A upon immortalization.
Munro, J., Stott, F. J., Vousden, K. H., Peters, G., & Parkinson, E. K. (1999) · PubMed · Cited by 93
Family matters: How MYC family oncogenes impact small cell lung cancer
Brägelmann, J., Böhm, S., Guthrie, M. R., Mollaoglu, G., Oliver, T. G., & Sos, M. L. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1339849 · Cited by 95

Authors: Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F.
Affiliations: St. Jude Children's Research Hospital (US)
ORCID: Eischen, Christine M.
Kamijo, Takehiko
Cleveland, John L.
Sherr, Charles J.
Roussel, Martine F.
Venue: Genes & Development
Publisher: Cold Spring Harbor Laboratory
Published: 1998-08-01
Volume: 12
Issue: 15
Pages: 2424-2433
ISSN: 0890-9369 (ISSN-L)
1549-5477
DOI: 10.1101/gad.12.15.2424
PMC: PMC317045
OpenAlex: W2046958356
Cited by: 1,245
References: 60
Citations by year: 2026: 6 · 2025: 15 · 2024: 14 · 2023: 32 · 2022: 10 · 2021: 27 · 2020: 15 · 2019: 22 · 2018: 15 · 2017: 23 · 2016: 28 · 2015: 19 · 2014: 43 · 2013: 45 · 2012: 46
Type: posted content
Language: en
Open access: bronze
doi.org
Locations: Genes & Development (publishedVersion)
Europe PMC (PubMed Central) (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: St. Jude Children's Research Hospital (CA21765)
American Lebanese Syrian Associated Charities (CA 21765)
National Institutes of Health (5r01ca056819-08, CA21765))
National Cancer Institute (CA-71907, CA56819, P30CA021765, P01CA071907)
National Institute of Diabetes and Digestive and Kidney Diseases (DK 44158, R01DK044158)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: MYC signaling, ARF tumor suppressor, p53, apoptosis, cell immortalization, p19ARF, TP53 mutation, oncogenic transformation
MeSH terms: Animals, Cell Division, Cell Line, Humans, Models, Biological, Mutation, Proteins, Signal Transduction, Gene Expression, Genes, Tumor Suppressor, Genes, p53, Genes, myc, Apoptosis, Gene Deletion, Tumor Suppressor Protein p14ARF, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks